Calogera Gerardi

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Medicine, Hematology, Pharmacology +6

Long‐term sequential deferiprone–deferoxamine <i>versus</i> deferiprone alone for thalassaemia major patients: a randomized clinical trial

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · British Journal of Haematology · 2009 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +14

Feasibility, reproducibility, and reliability for the <i>T</i>*₂ iron evaluation at 3 T in comparison with 1.5 T

Antonella Meloni, Vincenzo Positano, Petra Keilberg et al. · Magnetic Resonance in Medicine · 2011 · 66 citations · Full text

Medicine, Hematology, Radiology +17

Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · British Journal of Haematology · 2013 · 61 citations

Medicine, Cardiology, Hematology +17

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Angela Vitrano, Giuseppina Calvaruso, Eliana Lai et al. · British Journal of Haematology · 2016 · 56 citations · Full text

Medicine, Hematology, Internal Medicine +12